Xavier Nady headed for Tommy John elbow surgery

Leave a comment

As expected, the Yankees have confirmed that Xavier Nady will undergo season-ending Tommy John elbow surgery, likely ending his time in New York after just 66 games.

Nady was acquired from the Pirates last July with his value at an
all-time high thanks to a fluky .330 batting average, but he’d hit a
more modest .272/.327/.441 coming into the season and predictably
regressed to those numbers by batting .268/.320/.474 in 59 post-trade
games with the Yankees.

Nady took over as the Yankees’ starting right fielder this season
following the departure of free agent Bobby Abreu, but played just
seven games before leaving a mid-April game with a “sharp pain” in his
elbow. Reports immediately surfaced that he’d need surgery, but Nady
opted instead to rehab the injury and appeared to be making solid
progress in his recovery before suffering a setback in a minor-league
game last week.

Now he’s facing 9-12 months on the sidelines and the Yankees seem
unlikely to make a strong effort to re-sign the impending free agent
when bigger, healthier bats will no doubt be available this winter. All
of which means that they’ll end up parting with Jose Tabata, Ross
Ohlendorf, Jeff Karstens, and Daniel McCutcheon for 66 games of Nady
hitting .270/.319/.469 and 23.2 innings of a 7.61 ERA from Damaso
Marte.

Meanwhile, the Pirates have already gotten 238 innings of 4.57 ERA
pitching from Ohlendorf and Karstens, both of whom are in their mid-20s
and under team control at low salaries for the foreseeable future.
Tabata was actually the centerpiece of the deal and at 20 years old
still has considerable long-term upside, but he’s battled injuries
while hitting just .269/.343/.359 in 135 games at Double-A since the
trade.

Danny Espinosa reportedly skipped Nationals Winterfest because of Adam Eaton

WASHINGTON, DC - OCTOBER 13: Danny Espinosa #8 of the Washington Nationals celebrates after teammate Chris Heisey #14 (not pictured) hits a two run home run in the seventh inning against the Los Angeles Dodgers during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Rob Carr/Getty Images)
Getty Images
7 Comments

According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.

A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.

Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.

Espinosa will reach free agency after the 2017 season.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
10 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.